Back to Search
Start Over
Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex).
- Source :
-
BMJ case reports [BMJ Case Rep] 2020 Nov 03; Vol. 13 (11). Date of Electronic Publication: 2020 Nov 03. - Publication Year :
- 2020
-
Abstract
- A 59-year-old man with diabetic macular oedema was treated with a dexamethasone intravitreal implant (Ozurdex) to his right eye. Immediately after injection, the implant was noted to have extruded into the perilimbal subconjunctival space. The remnants of the implant were expeditiously removed the following day to avoid corneal decompensation and permanent corneal oedema. Endothelial decompensation secondary to the migration of dexamethasone implants into the subconjunctival space or anterior chamber is a recognised complication of Ozurdex injection. The patient recovered well postoperatively with no further complications. He was planned for a new Ozurdex implant 1 month later.<br />Competing Interests: Competing interests: None declared.<br /> (© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Subjects :
- Anterior Chamber
Dexamethasone administration & dosage
Foreign-Body Migration etiology
Glucocorticoids administration & dosage
Glucocorticoids adverse effects
Humans
Intravitreal Injections
Male
Middle Aged
Dexamethasone adverse effects
Drug Implants adverse effects
Foreign-Body Migration diagnosis
Macular Edema drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1757-790X
- Volume :
- 13
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- BMJ case reports
- Publication Type :
- Academic Journal
- Accession number :
- 33148568
- Full Text :
- https://doi.org/10.1136/bcr-2020-235102